Dr Lal Pathlabs informs about schedule of analyst meet

04 Sep 2019

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting. 

The above information is a part of company’s filings submitted to BSE.

Related Dr. Lal Pathlabs Ltd. Links:

Dr Lal Pathlabs Share Price

1627.55 -12.50 (-0.76%) Feb 28, 17:57
1 Year Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 1722.20
Aster DM Healthcare 161.85
Narayana Hrudayalay 332.15
Dr Lal Pathlabs 1627.55
Indraprastha Medical 39.95
View more..
Sensex vs Dr Lal Pathlabs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463